{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:07:32Z","timestamp":1789189652866,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pcad.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:22:12Z","timestamp":1775604132000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI"],"prefix":"10.1016","volume":"96","author":[{"given":"Aneta","family":"Aleksova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milijana","family":"Janjusevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Paolo","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dozio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Vanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Zandon\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Barbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Lucia","family":"Fluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pcad.2026.04.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254008","article-title":"Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes","volume":"16","author":"Gouda","year":"2021","journal-title":"PloS One"},{"issue":"19","key":"10.1016\/j.pcad.2026.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.pcad.2026.04.003_bb0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/clc.22583","article-title":"Residual ischemic risk and its determinants in patients with previous myocardial infarction and without prior stroke or TIA: insights from the REACH registry","volume":"39","author":"Abtan","year":"2016","journal-title":"Clin. Cardiol."},{"issue":"16","key":"10.1016\/j.pcad.2026.04.003_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169168","article-title":"From classic to modern prognostic biomarkers in patients with acute myocardial infarction","volume":"23","author":"Statescu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pcad.2026.04.003_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1142644","article-title":"New insights on the cardiovascular effects of IGF-1","volume":"14","author":"Macvanin","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.pcad.2026.04.003_bb0030","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1210\/clinem\/dgad105","article-title":"Insulin-like growth factor 1 and risk of cardiovascular disease: results from the UK biobank cohort study","volume":"108","author":"Lin","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcad.2026.04.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120193","article-title":"The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases","volume":"289","author":"Janjusevic","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.pcad.2026.04.003_bb0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijcard.2016.08.322","article-title":"U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction","volume":"223","author":"Aleksova","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.pcad.2026.04.003_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.numecd.2014.08.012","article-title":"Epicardial adipose tissue inflammation is related to vitamin D deficiency in patients affected by coronary artery disease","volume":"25","author":"Dozio","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"43","key":"10.1016\/j.pcad.2026.04.003_bb0050","doi-asserted-by":"crossref","first-page":"25461","DOI":"10.1074\/jbc.270.43.25461","article-title":"Insulin-like growth factor I, a unique calcium-dependent stimulator of 1,25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells","volume":"270","author":"Menaa","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pcad.2026.04.003_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1162442","article-title":"Causal associations between insulin-like growth factor 1 and vitamin D levels: a two-sample bidirectional mendelian randomization study","volume":"10","author":"Gou","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12967-019-1840-4","article-title":"Vitamin D and growth hormone in children: a review of the current scientific knowledge","volume":"17","author":"Esposito","year":"2019","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.pcad.2026.04.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102272","article-title":"Vitamin D3 induces mesenchymal-to-endothelial transition and promotes a proangiogenic niche through IGF-1 signaling","volume":"24","author":"Chen","year":"2021","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.pcad.2026.04.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035620","article-title":"Amyloid beta1-40 predicts long-term mortality rate in patients with acute myocardial infarction","volume":"14","author":"Aleksova","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"38","key":"10.1016\/j.pcad.2026.04.003_bb0075","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.pcad.2026.04.003_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.pcad.2026.04.003_bb0085","first-page":"e18","article-title":"ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2026.04.003_bb0090","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2502066","article-title":"Left main coronary artery disease: a contemporary review of diagnosis and management","volume":"25","author":"Khawaja","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"issue":"10075","key":"10.1016\/j.pcad.2026.04.003_bb0095","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.pcad.2026.04.003_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13226792","article-title":"The co-existence of hypovitaminosis D and diabetes mellitus triples the incidence of severe coronary artery disease in women","volume":"13","author":"Aleksova","year":"2024","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.pcad.2026.04.003_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jacc.2024.04.051","article-title":"Percutaneous coronary revascularization strategies after myocardial infarction: a systematic review and network meta-analysis","volume":"84","author":"Reddy","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.pcad.2026.04.003_bb0110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2169\/internalmedicine.47.0736","article-title":"Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction","volume":"47","author":"Yamaguchi","year":"2008","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.pcad.2026.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jc.2014-3968","article-title":"Impact of age-adjusted insulin-like growth factor 1 on major cardiovascular events after acute myocardial infarction: results from the fast-MI registry","volume":"100","author":"Bourron","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4330\/wjc.v9.i1.14","article-title":"Vitamin D and acute myocardial infarction","volume":"9","author":"Milazzo","year":"2017","journal-title":"World J. Cardiol."},{"issue":"4","key":"10.1016\/j.pcad.2026.04.003_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4274\/ijca.2024.51523","article-title":"Association between vitamin D deficiency and angiographic severity in patients with coronary artery disease","volume":"10","author":"Sahani","year":"2024","journal-title":"Int. J. Cardiovasc. Acad."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymthe.2018.10.020","article-title":"IGF1 treatment improves cardiac remodeling after infarction by targeting myeloid cells","volume":"27","author":"Heinen","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pcad.2026.04.003_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908023","article-title":"Insulin-like growth factor 1 attenuates the pro-inflammatory phenotype of neutrophils in myocardial infarction","volume":"13","author":"Nederlof","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.pcad.2026.04.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037279","article-title":"Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: a review","volume":"103","author":"Yan","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pcad.2026.04.003_bb0145","series-title":"Endotext","article-title":"Vitamin D: production, metabolism and mechanisms of action","author":"Bikle","year":"2000"},{"issue":"2","key":"10.1016\/j.pcad.2026.04.003_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ecl.2012.04.008","article-title":"Insulin-like growth factor 1 physiology: lessons from mouse models","volume":"41","author":"Yakar","year":"2012","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.pcad.2026.04.003_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2019.01.002","article-title":"IGF-1 and cardiovascular disease","volume":"45","author":"Higashi","year":"2019","journal-title":"Growth Horm. IGF Res."},{"issue":"3","key":"10.1016\/j.pcad.2026.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1210\/jc.2004-0545","article-title":"Clinical review: growth hormone and cardiovascular risk factors","volume":"90","author":"Gola","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.pcad.2026.04.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0735-1097(01)01367-5","article-title":"Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction","volume":"38","author":"Conti","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.pcad.2026.04.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-25-0077","article-title":"Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1","volume":"265","author":"Boettger","year":"2025","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pcad.2026.04.003_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coemr.2018.11.001","article-title":"IGF-I and the endocrinology of aging","volume":"5","author":"Janssen","year":"2019","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.pcad.2026.04.003_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630503","article-title":"Growth hormone\/insulin growth factor axis in sex steroid associated disorders and related cancers","volume":"9","author":"Bleach","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.pcad.2026.04.003_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/endrev\/bnae009","article-title":"Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows","volume":"45","author":"Giustina","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.pcad.2026.04.003_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2018.08.052","article-title":"Left ventricular adverse remodeling after myocardial infarction and its association with vitamin D levels","volume":"277","author":"Padoan","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.pcad.2026.04.003_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072127","article-title":"Diabetes mellitus and vitamin D deficiency:comparable effect on survival and a deadlyassociation after a myocardial infarction","volume":"9","author":"Aleksova","year":"2020","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.pcad.2026.04.003_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052153","article-title":"Vitamin D and type 2 diabetes mellitus: molecular mechanisms and clinical implications-a narrative review","volume":"26","author":"Fuentes-Barria","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.pcad.2026.04.003_bb0210","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1210\/clinem\/dgaa594","article-title":"Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D?","volume":"105","author":"Pittas","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/jc.2003-030967","article-title":"The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study","volume":"89","author":"Laughlin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.pcad.2026.04.003_bb0220","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1210\/clinem\/dgad212","article-title":"IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all causes in EPIC-Heidelberg","volume":"108","author":"Mukama","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.pcad.2026.04.003_bb0225","first-page":"1575","article-title":"Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling","volume":"84","author":"Lee","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.pcad.2026.04.003_bb0230","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1530\/EC-21-0175","article-title":"Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays","volume":"10","author":"Sabbah","year":"2021","journal-title":"Endocr. Connect."},{"issue":"7","key":"10.1016\/j.pcad.2026.04.003_bb0235","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/gerona\/glx143","article-title":"Trajectories of IGF-I predict mortality in older adults: the cardiovascular health study","volume":"73","author":"Sanders","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"12","key":"10.1016\/j.pcad.2026.04.003_bb0240","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/clinchem\/48.12.2248","article-title":"Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies","volume":"48","author":"Borofsky","year":"2002","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/en.2014-1519","article-title":"The antidiabetic hormone glucagon-like peptide-1 induces formation of new elastic fibers in human cardiac fibroblasts after cross-activation of IGF-IR","volume":"156","author":"Qa\u2019aty","year":"2015","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pcad.2026.04.003_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165713","article-title":"Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia","volume":"8","author":"Sukhanov","year":"2023","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pcad.2026.04.003_bb0255","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1097\/HCR.0000000000000930","article-title":"Core components of cardiac rehabilitation programs: 2024 update: a scientific statement from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation: endorsed by the American College of Cardiology","volume":"45","author":"Brown","year":"2025","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"10.1016\/j.pcad.2026.04.003_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846903","article-title":"Mini review: effect of GLP-1 receptor agonists and SGLT-2 inhibitors on the growth hormone\/IGF axis","volume":"13","author":"Cignarelli","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.pcad.2026.04.003_bb0265","doi-asserted-by":"crossref","first-page":"22661","DOI":"10.1038\/s41598-024-72783-4","article-title":"Murine neonatal cardiac regeneration depends on insulin-like growth factor 1 receptor signaling","volume":"14","author":"Schuetz","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.pcad.2026.04.003_bb0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwq005","article-title":"Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study","volume":"171","author":"Jorde","year":"2010","journal-title":"Am. J. Epidemiol."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062026000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:37:37Z","timestamp":1789187857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062026000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"alternative-id":["S0033062026000320"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2026.04.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}